Psoriatic arthropathy aggravated and Hyperventilation

Summary:

Hyperventilation is found among people with Psoriatic arthropathy aggravated, especially for people who are female, 40-49 old.

The study analyzes which people have Hyperventilation with Psoriatic arthropathy aggravated. It is created by eHealthMe based on reports of 49 people who have Psoriatic arthropathy aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psoriatic arthropathy aggravated?

Psoriatic arthropathy aggravated (serious inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop) is found to be associated with 788 drugs and 281 conditions by eHealthMe. Check the latest studies of Psoriatic arthropathy aggravated.

What is Hyperventilation?

Hyperventilation is found to be associated with 705 drugs and 1,444 conditions by eHealthMe. Check the latest studies of Hyperventilation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

49 people who have Psoriatic Arthropathy Aggravated and Hyperventilation are studied.

Would you have Hyperventilation when you have Psoriatic arthropathy aggravated?

Gender of people who have Psoriatic Arthropathy Aggravated and experienced Hyperventilation *:

female: 73.17 %
male: 26.83 %

Age of people who have Psoriatic Arthropathy Aggravated and experienced Hyperventilation *:

Common co-existing conditions for these people *:

Psoriasis (immune-mediated disease that affects the skin): 9 people, 18.37%
High Blood Pressure: 5 people, 10.20%
Joint Pain: 4 people, 8.16%
Pain: 3 people, 6.12%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 3 people, 6.12%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 6.12%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 4.08%
Asthma: 2 people, 4.08%
Hypersensitivity: 2 people, 4.08%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 4.08%

Common drugs taken by these people *:

Common symptoms for these people *:

Nausea (feeling of having an urge to vomit): 22 people, 44.90%
Stress And Anxiety: 21 people, 42.86%
Weakness: 19 people, 38.78%
Fatigue (feeling of tiredness): 19 people, 38.78%
Joint Pain: 18 people, 36.73%
Gait Disturbance: 17 people, 34.69%
Dizziness: 17 people, 34.69%
Malaise (a feeling of general discomfort or uneasiness): 16 people, 32.65%
Fever: 16 people, 32.65%
General Physical Health Deterioration (weak health status): 16 people, 32.65%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Psoriatic arthropathy aggravated (13 reports)
Hyperventilation (8,309 reports)

All the drugs that are associated with Hyperventilation:

Hyperventilation (705 drugs)

All the conditions that are associated with Hyperventilation:

Hyperventilation (1,444 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperventilation and Psoriatic arthropathy aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.